Journal List > Korean J Neurotrauma > v.8(2) > 1058881

Efficacy of Short-Term versus Long-Term Post-Operative Antimicrobial Prophylaxis for Preventing Surgical Site Infection after Clean Neurosurgical Operations

Abstract

Objective:

Surgical site infection (SSI) is a problem constantly uppermost in the minds of all surgeons, although the actual rate of occurrence is only 1-5% in general surgery. In neurosurgical fields, there have been a few papers published about efficacy of post-operative antimicrobial prophylaxis (PAMP) to prevent SSI, compared to well known effectiveness of preoperative antibiotics. Thus, infection rates of short-term PAMP groups and those of long-term PAMP groups were investigated to evaluate the effectiveness of PAMP and the efficacy of short-term PAMP compared to long-term PAMP for prevention of SSI.

Methods:

Between April 2010 and April 2012, we retrospectively analyzed the data of 35 patients in the aneurysmal neck clipping groups (short-term PAMP group: PAMP for 3 days and fewer, long-term PAMP group: PAMP for 10 days and more) and 79 patients in the microdiscectomy groups (short-term PAMP group: 3 days and fewer, long-term PAMP group: PAMP for 6 days and more).

Results:

In aneurysmal neck clipping groups, SSI occurred 23.1% of short-term PAMP group and 9.1% of long-term PAMP group (p=0.3370). And in microdiscectomy groups, SSI occurred 6.7% of short-term PAMP group and 4.1% of long-term PAMP group (p=0.9840).

Conclusion:

There is no significant difference between the short-term PAMP group and the long-term PAMP group in terms of SSI, regardless of operation type. We therefore suggest that short-term PAMP usage could be an appropriate therapy for preventing SSI in clean neurosurgical operations.

REFERENCES

1). Antimicrobial prophylaxis in neurosurgery and after head injury. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Lancet. 344:1547–1551. 1994.
2). ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm. 56:1839–1888. 1999.
3). Barker FG 2nd. Efficacy of prophylactic antibiotic therapy in spinal surgery: a meta-analysis. Neurosurgery. 51:391–400. discussion 400-401. 2002.
crossref
4). Barker FG 2nd. Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis. Neurosurgery. 60:887–894. discussion 887-894. 2007.
crossref
5). Brown EM. Antimicrobial prophylaxis in neurosurgery. J Antimicrob Chemother 31 Suppl B: 49-63. 1993.
crossref
6). Castella A., Charrier L., Di Legami V., Pastorino F., Farina EC., Ar-gentero PA, et al. Surgical site infection surveillance: analysis of adherence to recommendations for routine infection control practices. Infect Control Hosp Epidemiol. 27:835–840. 2006.
crossref
7). de Lissovoy G., Fraeman K., Hutchins V., Murphy D., Song D., Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 37:387–397. 2009.
crossref
8). Dellinger EP., Gross PA., Barrett TL., Krause PJ., Martone WJ., Mc-Gowan JE Jr, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. The Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 15:182–188. 1994.
9). Durando P., Bassetti M., Orengo G., Crimi P., Battistini A., Bellina D, et al. Adherence to international and national recommendations for the prevention of surgical site infections in Italy: Results from an observational prospective study in elective surgery. Am J Infect Control, 2012 [Epub ahead of print].
10). Fry DE. Fifty ways to cause surgical site infections. Surg Infect (Larchmt). 12:497–500. 2011.
crossref
11). Korinek AM., Baugnon T., Golmard JL., van Effenterre R., Coriat P., Puybasset L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 62 Suppl. 2:532–539. 2008.
12). Korinek AM., Golmard JL., Elcheick A., Bismuth R., van Effenterre R., Coriat P, et al. Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4,578 patients. Br J Neurosurg. 19:155–162. 2005.
crossref
13). Lee KY., Coleman K., Paech D., Norris S., Tan JT. The epidemiology and cost of surgical site infections in Korea: a systematic review. J Korean Surg Soc. 81:295–307. 2011.
crossref
14). Lietard C., Thébaud V., Besson G., Lejeune B. Risk factors for neurosurgical site infections: an 18-month prospective survey. J Neurosurg. 109:729–734. 2008.
crossref
15). Mangram AJ., Horan TC., Pearson ML., Silver LC., Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 27:97–132. quiz 133-134; discussion 96. 1999.
16). Nichols RL. Surgical antibiotic prophylaxis. Med Clin North Am. 79:509–522. 1995.
crossref
17). Patir R., Mahapatra AK., Banerji AK. Risk factors in postoperative neurosurgical infection. A prospective study. Acta Neurochir (Wien). 119:80–84. 1992.
18). Pople I., Poon W., Assaker R., Mathieu D., Iantosca M., Wang E, et al. Comparison of infection rate with the use of antibiotic-impregnated vs standard extraventricular drainage devices: a prospective, randomized controlled trial. Neurosurgery. 71:6–13. 2012.
19). Ryska O., Serclová Z., Konecná E., Fulík J., Kneifl T., Dytrych P, et al. [Antibiotic prophylaxis in acute surgical procedures—the current praxis in Czech Republic]. Rozhl Chir. 90:402–407. 2011.
20). Tanner J., Swarbrook S., Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev: CD004288. 2008.
crossref
21). Waddell TK., Rotstein OD. Antimicrobial prophylaxis in surgery. Committee on Antimicrobial Agents, Canadian Infectious Disease Society. CMAJ. 151:925–931. 1994.
22). Webster J., Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev: CD004985. 2006.
crossref

FIGURE 1.
Patient population profile. PAMP inappropriate duration: patient who prescribed post-operative antibiotics from 4 days to 9 days after surgery in aneurysmal neck clipping group and patient who prescribed post operative antibiotics from 4 days to 6 days after surgery in microdiscectomy group. PAMP: post operative antimicrobial prophylaxis.
kjn-8-104f1.tif
FIGURE 2.
Operation time of group A.
kjn-8-104f2.tif
FIGURE 3.
Operation time of group B.
kjn-8-104f3.tif
TABLE 1.
Demographic data of aneurysmal neck clipping group
  Group A1 (n=13) Group A2 (n=22) p-value
Sex     0.2925
Men 06 06  
Women 07 16  
Age 049.17±11.040 054.67±9.9000 0.1507
Hypertension     0.7260
Present 05 07  
Absent 08 15  
Diabetes mellitus     0.5193
Present 00 02  
Absent 13 20  
Smoking history     0.4630
Yes 03 09  
No 10 13  
BMI 022.65±3.1000 023.11±2.2700 0.6126
Operation time 418.46±107.28 363.41±102.16 0.1399

Continuous variables are expressed as mean±standard deviation, A1: aneurysmal neck clipping with short-term PAMP group, A2: aneurysmal neck clipping with long-term PAMP group. BMI: body mass index, PAMP: post-operative antimicrobial prophylaxis

TABLE 2.
Demographic data of microdiscectomy group
  Group B1 (n=30) Group B2 (n=49) p-value
Sex     0.1739
Men 19 22  
Women 11 27  
Age 051.17±15.77 050.67±13.77 0.8842
Hypertension     0.2416
Present 07 19  
Absent 23 30  
Diabetes mellitus     0.9077
Present 05 10  
Absent 25 39  
Smoking history     0.5558
Yes 80 09  
No 22 40  
BMI 024.32±03.18 024.40±03.95 0.9284
Operation time 148.67±89.80 141.22±87.81 0.7180

Continuous variables are expressed as mean±standard deviation, B1: microdiscectomy with short-term PAMP group, B2: microdiscectomy with long-term PAMP group. BMI: body mass index, PAMP: post-operative antimicrobial prophylaxis

TABLE 3.
Distribution patterns of surgical site infected patients
  Group A1 (n=13) Group A2 (n=22) p-value
Infection      
Present 03 02  
Absent 10 20  
Rate 23.1% 9.1% 0.3370
  Group B1 (n=30) Group B2 (n=49) p-value
Infection      
Present 02 02  
Absent 28 47  
Rate 06.7% 4.1% 0.9840

A1: aneurysmal neck clipping with short-term PAMP group, A2: aneurysmal neck clipping with long-term PAMP group, B1: microdiscectomy with short-term PAMP group, B2: microdiscectomy with long-term PAMP group, PAMP: post-operative antimicrobial prophylaxis

TABLE 4.
Characteristics of SSI patient in aneurysmal neck clipping group
Case Group Sex Age Infection type Operation time DM Smoking BMI
1 A1 M 43 D 10 hr N N 29.41
2 A1 F 52 S 8 hr 25 min N Y 20.60
3 A1 F 25 S 5 hr N N 26.58
4 A2 F 67 D 7 hr 20 min Y Y 23.18
5 A2 F 61 S 5 hr N Y 28.11

A1: aneurysmal neck clipping with short-term PAMP group, A2: aneurysmal neck clipping with long-term PAMP group, M: male, F: female, DM: diabetes mellitus, BMI: body mass index, D: deep infection, S: superficial infection, Y: yes, N: no, PAMP: postoperative antimicrobial prophylaxis, SSI: surgical site infection

TABLE 5.
Characteristics of SSI patient in microdiscectomy group
Case Group Sex Age Infection type Operation time DM Smoking BMI
6 B1 M 62 S 5 hr 10 min N N 26.06
7 B1 F 58 D 3 hr 25 min N N 26.24
8 B2 F 61 D 2 hr 15 min Y Y 25.15
9 B2 F 67 S 1 hr 50 min N Y 35.03

B1: microdiscectomy with short-term PAMP group, B2: microdiscectomy with long-term PAMP group, M: male, F: female, DM: diabetes mellitus, BMI: body mass index, D: deep infection, S: superficial infection, Y: yes, N: no, PAMP: post-operative antimicrobial prophylaxis, SSI: surgical site infection

TOOLS
Similar articles